USFDA has returned to the drawing board with some draft advice to in vitro diagnostic device manufacturers on what types of studies are needed to qualify a test for use at the point of care.
Two new draft guidances were postedby the agency Nov
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?